WA govt waits to be convinced on GM benefits
17 June, 2002 by Pete YoungThe Western Australian government is approaching zero hour on the issue of whether to ban genetically-modified (GM) commercial food crops, says Agriculture Minister Kim Chance.
SDI champing at the bit for projected profit jump
14 June, 2002 by Tanya HollisDental materials manufacturer SDI is tracking for a 40 per cent full-year profit jump on the back of the company's R&D investment and push into global markets.
US orthopaedic company to test pSiMedica nanomaterials
14 June, 2002 by Melissa TrudingerpSiMedica, the UK subsidiary of WA-based company pSiVida, has signed a materials exchange research agreement with Implex Corporation, a US orthopaedic products company.
Eiffel in second deal with US pharma
14 June, 2002 by Tanya HollisDrug reformulation company Eiffel Technologies has signed a one-year contract with specialist pulmonary medicines maker BattellePharma to create nanoparticles for the United States group's asthma product.
Grains board backs genetic treaty signing
14 June, 2002 by Melissa TrudingerThe head of the Grains Research and Development Corporation (GRDC), Dr John Lovett, has supported this week's signing by the Australian government of the International Treaty on Plant Genetic Resources for Food and Agriculture.
Axon implements cost-cutting in bid to cushion losses
14 June, 2002 by Tanya HollisSalary freezes, a reduction in voluntary superannuation fund contributions and modest job cuts in the United States are among several cost cutting measures underway at Axon Instruments to pare back its losses over the coming year.
Benitec's big Bio splash
14 June, 2002 by Melissa TrudingerUntil this week, Benitec (ASX: BLT) was a small, virtually unsung Queensland biotech company. But that changed at this week's Bio 2002 conference in Toronto, where the company showcased its gene silencing technology, which it claims will revolutionise gene control.
OGTR seeks GM cotton input
13 June, 2002 by Melissa TrudingerThe Office of the Gene Technology Regulator (OGTR) has called for public comment on two licence applications for Monsanto's GM cotton.
Clinical trials facility to be built in Queensland
13 June, 2002 by Pete YoungThe first custom-designed facility to conduct Phase I clinical drug trials in Queensland will be built as part of a new start-up company, Q-Pharm.
Cytopia strengthens deals with US biotech Chemicon
13 June, 2002 by Tanya HollisImmune disease drug discovery company Cytopia has again joined forces with Californian life sciences group Chemicon International, this time to develop and commercialise recombinant protein kinases.
WA researchers developing virus-resistant legumes
12 June, 2002 by Melissa TrudingerScientists at the Centre for Legumes in a Mediterranean Climate (CLIMA) in Western Australia are using transgenic techniques to develop new varieties of legumes with resistance to viruses.
Cbio announces drug manufacture success
12 June, 2002 by Melissa TrudingerCbio announced at the Bio 2002 conference in Toronto that it had successfully manufactured its first drug, called Early Pregnancy Factor (EPF), and was on track to start its first clinical trials next year.
US deal puts Axon on track for new screening product
11 June, 2002 by Tanya HollisInstrumentation and software developer Axon Instruments has signed an exclusive deal with the US maker of an electrode device that can be used to scan potential drugs for use in heart disease, chronic pain, diabetes, high blood pressure and migraine.
Biotron R&D effort boosted by Waters deal
11 June, 2002 by Melissa TrudingerInstrumentation company Waters Australia will be assisting Canberra-based Biotron in its CT-1 cancer biomarker project, according to details of a new collaboration.
Norwood Abbey patent success
11 June, 2002 by Tanya HollisAustralian technology enabling the collection of intracellular fluid for analyte measurement without the use of a needle has gained a United States patent.
